The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon

A physiological flow model is presented to account for plasma level double peaks based on cyclical gastric emptying and intestinal motility in the fasted state. Central to the model is the assumption that gastric emptying and intestinal transit rates will vary directly with the strength of the contractile activity characteristic of the fasted state motility cycle. Simulated curves clearly indicate that variable gastric emptying rates can result in variable absorption rates from the gastrointestinal tract and double peaks in the plasma level curves of cimetidine. Vital to the occurrence of double peaks are (i) dosing time relative to phasic activity, (ii) variability in flow out of the stomach, and (iii) a small emptying rate constant Qs/Vs, for a period of time within the first hour after administration. Variability in intestinal flow rates alone does not cause a double peak in the plasma level curve. Results of the simulations, as well as experimental results, can be categorized according to the shapes of the plasma level curves into four types: type A, Cpmax(1) Cpmax(2); type D, Cpmax(1)=Cpmax(2). Assuming that the experimental results were obtained from fasted subjects, with the time of dose administration being a random variable, the frequency of the experimental curves having shape A, B, C, or D correlates extremely well with theoretical predictions. It is concluded that variable gastric emptying rates due to the motility cycle can account for plasma level double peaks. Furthermore, variable gastric emptying rates combined with the short plasma elimination half-life and poor gastric absorption of cimetidine can be the cause of the frequently observed plasma level double peaks.

[1]  P. Fleckenstein,et al.  Electrical spike activity in the human small intestine , 1978, The American Journal of Digestive Diseases.

[2]  G. Amidon,et al.  Application of a radiotelemetric system to evaluate the performance of enteric coated and plain aspirin tablets. , 1986, Journal of pharmaceutical sciences.

[3]  R. Heading,et al.  Effect of cimetidine on serum gastrin and gastric emptying in man. , 1978, Digestion.

[4]  J. Webster,et al.  Cimetidine-a clinical and pharmacokinetic study. , 1981, British journal of clinical pharmacology.

[5]  P. Veng Pedersen Pharmacokinetic analysis by linear system approach I: cimetidine bioavailability and second peak phenomenon. , 1981, Journal of pharmaceutical sciences.

[6]  L. Paalzow,et al.  Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis , 2004, European Journal of Clinical Pharmacology.

[7]  J. Barrowman,et al.  Clinical Gastrointestinal Physiology , 1985 .

[8]  R. R. Levine Factors affecting gastrointestinal absorption of drugs , 1970, The American Journal of Digestive Diseases.

[9]  A. Rosén,et al.  Bioavailability and pharmacokinetics of cimetidine , 1979, European Journal of Clinical Pharmacology.

[10]  P. Tothill,et al.  The dependence of paracetamol absorption on the rate of gastric emptying , 1973, British journal of pharmacology.

[11]  S. Sarna Cyclic motor activity; migrating motor complex: 1985. , 1985, Gastroenterology.

[12]  L Bueno,et al.  Rate of flow of digesta and electrical activity of the small intestine in dogs and sheep. , 1975, The Journal of physiology.

[13]  Y. Ruckebusch,et al.  The propagation of segmental contractions along the small intestine * , 1972, The Journal of physiology.

[14]  W. J. Westlake,et al.  Bioavailability of cimetidine in man , 1978 .

[15]  C. Dooley,et al.  Effects of aspirin and prostaglandin E2 on interdigestive motility complex and duodenogastric reflux in man , 1985, Digestive Diseases and Sciences.

[16]  P. Tothill,et al.  Inhibition of gastric emptying and drug absorption by narcotic analgesics. , 1975, British journal of clinical pharmacology.

[17]  P. Pedersen Pharmacokinetic analysis by linear system approach I: Cimetidine bioavailability and second peak phenomenon , 1981 .

[18]  T. Borody,et al.  Human interdigestive motility: variations in patterns from esophagus to colon. , 1986, Gastroenterology.

[19]  J. Wagner,et al.  Comparative bioavailability study of two tablet formulations of cimetidine. , 1984, Biopharmaceutics & drug disposition.

[20]  R. Miller,et al.  Pharmacokinetics and bioavailability of cimetidine in humans. , 1980, Journal of pharmaceutical sciences.

[21]  W. Nimmo Drugs, Diseases and Altered Gastric Emptying , 1976, Clinical pharmacokinetics.

[22]  C F Code,et al.  The interdigestive myo‐electric complex of the stomach and small bowel of dogs. , 1975, The Journal of physiology.

[23]  J. Robinson,et al.  Gastric emptying of liquids in the fasted dog , 1988 .

[24]  L F Prescott,et al.  Kinetics of acetaminophen absorption and gastric emptying in man , 1978, Clinical pharmacology and therapeutics.

[25]  J. N. Hunt,et al.  The influence of volume on gastric emptying , 1954, The Journal of physiology.

[26]  T. Whittingham,et al.  Measurement of gastric emptying by real-time ultrasound. , 1982, Gut.

[27]  P. Fleckenstein,et al.  Migrating electrical spike activity in the fasting human small intestine , 1978, The American Journal of Digestive Diseases.

[28]  G. Bodemar,et al.  The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine--studies in patients with peptic ulcer disease. , 1979, British journal of clinical pharmacology.